ACCESS-AD

A pan-European partnership bridging innovation to clinical practice, advancing timely diagnosis and equitable treatment of Alzheimer's disease.

[ACCESS-AD @IHI_Access_AD]

👋Hello from ACCESS-AD!

We’re delighted to launch ACCESS-AD, a new IHI project focused on bringing #Alzheimer’s disease innovation into routine clinical practice - supporting timely diagnosis, treatment & monitoring across 🇪🇺

Read our press release: https://t.co/NePftsePeh

[ACCESS-AD @IHI_Access_AD]

🌟and that's a wrap!🌟

Today, we concluded two busy days for ACCESS-AD: our very first General Assembly, hosted in 🇳🇱 & bringing together colleagues from our 30 partner organisations.

👀 for a summary on the ACCESS-AD website - in the meantime, enjoy these team photos 💜

[ACCESS-AD @IHI_Access_AD]

Missed the ACCESS-AD launch and want to learn more?

Visit our website ▶️ https://t.co/4VUdhVjBU2
Check out our press release 📖https://t.co/5bLXqVJ24w
....and follow along for updates as our work moves forward!

[ACCESS-AD @IHI_Access_AD]

Earlier this week, we launched ACCESS-AD 🚀
Today, we’re sharing a short video on how our IHI project aims to support earlier diagnosis, safer treatment and better monitoring for #Alzheimer’s disease.
🎬 Watch the video to learn more and stay tuned!

[AD-RIDDLE @AD_RIDDLE]

📣Follow @IHI_Access_AD, a new IHI project, building on @IHI_PROMINENT @AD_RIDDLE @imi_epnd & @predictom, ensuring that advances in early detection, biomarker innovation and data infrastructure translate into improved diagnosis, treatment and care.

👉https://t.co/pINX9mmikj

[IHI Prominent @IHI_PROMINENT]

.@IHI_Access_AD builds on other IHI initiatives including @IHI_PROMINENT, @predictom , @AD_RIDDLE and @imi_epnd, ensuring that advances in early detection, biomarker innovation and data infrastructure translate into improved diagnosis, treatment and care.

[ACCESS-AD @IHI_Access_AD]

Want to learn more about ACCESS-AD and our consortium of 30 public and private partners?

Visit the ACCESS-AD website: https://t.co/3JAkywV0os

[ACCESS-AD @IHI_Access_AD]

👋Hello from ACCESS-AD!

We’re delighted to launch ACCESS-AD, a new IHI project focused on bringing #Alzheimer’s disease innovation into routine clinical practice - supporting timely diagnosis, treatment & monitoring across 🇪🇺

Read our press release: https://t.co/NePftsePeh